Pretax income is the income that a company earns before paying income taxes. Adynxx's pretax income for the
three
months ended in Sep. 2019 was $-1.90 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2019 was $-8.95 Mil.
Adynxx's pretax margin was %.
Adynxx Pre-Tax Income Historical Data
The historical data trend for Adynxx's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Adynxx's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adynxx's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Adynxx's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Adynxx's Pre-Tax Income falls into.
Adynxx Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Adynxx's Pretax Income for the fiscal year that ended in Dec. 2018 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adynxx (OTCPK:ADYX) Pre-Tax Income Explanation
Adynxx's Pretax Margin for the quarter that ended in Sep. 2019 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adynxx Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Adynxx's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ADYX has been successfully added to your 